Ladenburg Thalmann Financial Services’s Pulse Biosciences PLSE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q4
$74K Sell
5,500
-111
-2% -$1.58K ﹤0.01% 3244
2019
Q3
$87K Hold
5,611
﹤0.01% 3034
2019
Q2
$74K Hold
5,611
﹤0.01% 3191
2019
Q1
$99K Hold
5,611
﹤0.01% 2888
2018
Q4
$64K Hold
5,611
﹤0.01% 3084
2018
Q3
$80K Sell
5,611
-3,800
-40% -$54K ﹤0.01% 2985
2018
Q2
$127K Hold
9,411
﹤0.01% 2601
2018
Q1
$127K Buy
9,411
+2,711
+40% +$51.5K ﹤0.01% 2601
2017
Q4
$158K Buy
+6,700
New +$158K ﹤0.01% 2392
2017
Q3
Sell
-217
Closed -$7K 4997
2017
Q2
$7K Hold
217
﹤0.01% 4199
2017
Q1
$4K Buy
+217
New +$2.95K ﹤0.01% 4386

Other funds holding PLSE

Ladenburg Thalmann Financial Services's PLSE Position: Q4 2019 in Review

Ladenburg Thalmann Financial Services reduced its Pulse Biosciences (PLSE) stake by 2% in Q4 2019, selling an estimated $1.58K and leaving 5,500 shares worth $74K. The position accounts for ﹤0.01% of the portfolio, ranked #3244.

Ladenburg Thalmann Financial Services first reported a position in PLSE in Q1 2017 and has held it in 11 quarters since. The position peaked at $158K in Q4 2017. 45 funds tracked by Wall St. Rank hold PLSE as of Q4 2019.

  • Ladenburg Thalmann Financial Services held 5,500 shares of Pulse Biosciences worth $74K as of Q4 2019.
  • Ladenburg Thalmann Financial Services sold 111 Pulse Biosciences shares in Q4 2019, an estimated $1.58K.
  • Pulse Biosciences made up ﹤0.01% of Ladenburg Thalmann Financial Services's portfolio in Q4 2019, its #3244 holding.
  • Ladenburg Thalmann Financial Services first reported a position in Pulse Biosciences in Q1 2017 and has held it in 11 quarters since.
  • Ladenburg Thalmann Financial Services's Pulse Biosciences position peaked at $158K in Q4 2017.
  • 45 funds tracked by Wall St. Rank held Pulse Biosciences as of Q4 2019.

Based on Ladenburg Thalmann Financial Services's 13F filing for Q4 2019, filed 14 Feb 2020.